1. Home
  2. ARGX vs WDC Comparison

ARGX vs WDC Comparison

Compare ARGX & WDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARGX
  • WDC
  • Stock Information
  • Founded
  • ARGX 2008
  • WDC 1970
  • Country
  • ARGX Netherlands
  • WDC United States
  • Employees
  • ARGX N/A
  • WDC N/A
  • Industry
  • ARGX Biotechnology: Biological Products (No Diagnostic Substances)
  • WDC Electronic Components
  • Sector
  • ARGX Health Care
  • WDC Technology
  • Exchange
  • ARGX Nasdaq
  • WDC Nasdaq
  • Market Cap
  • ARGX 51.1B
  • WDC 41.3B
  • IPO Year
  • ARGX 2017
  • WDC N/A
  • Fundamental
  • Price
  • ARGX $917.87
  • WDC $160.51
  • Analyst Decision
  • ARGX Strong Buy
  • WDC Buy
  • Analyst Count
  • ARGX 17
  • WDC 23
  • Target Price
  • ARGX $910.63
  • WDC $146.39
  • AVG Volume (30 Days)
  • ARGX 367.0K
  • WDC 10.0M
  • Earning Date
  • ARGX 10-30-2025
  • WDC 10-30-2025
  • Dividend Yield
  • ARGX N/A
  • WDC 0.32%
  • EPS Growth
  • ARGX N/A
  • WDC 578.01
  • EPS
  • ARGX 23.27
  • WDC 6.90
  • Revenue
  • ARGX $3,683,281,000.00
  • WDC $10,126,000,000.00
  • Revenue This Year
  • ARGX $85.93
  • WDC $21.38
  • Revenue Next Year
  • ARGX $35.17
  • WDC $9.29
  • P/E Ratio
  • ARGX $36.91
  • WDC $22.87
  • Revenue Growth
  • ARGX 92.98
  • WDC 75.22
  • 52 Week Low
  • ARGX $510.06
  • WDC $28.83
  • 52 Week High
  • ARGX $934.13
  • WDC $178.45
  • Technical
  • Relative Strength Index (RSI)
  • ARGX 70.28
  • WDC 58.58
  • Support Level
  • ARGX $897.50
  • WDC $132.43
  • Resistance Level
  • ARGX $932.29
  • WDC $163.78
  • Average True Range (ATR)
  • ARGX 19.86
  • WDC 10.45
  • MACD
  • ARGX -0.28
  • WDC -2.08
  • Stochastic Oscillator
  • ARGX 82.07
  • WDC 60.71

About ARGX argenx SE

Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases. The company's lead product, Vyvgart (efgartigimod), was approved by the FDA in December 2021 for the treatment of generalized myasthenia gravis (gMG). In 2022, Argenx also received FDA approval for Vyvgart Hytrulo, a subcutaneous formulation of Vyvgart, offering a more convenient option compared with Vyvgart's intravenous administration. In 2024, the FDA approved Vyvgart Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy, a rare immune-mediated neuromuscular disorder of the peripheral nervous system. Argenx is focused on innovation and developing its pipeline for treatments such as primary immune thrombocytopenia, thyroid eye disease, and Sjogren's Disease.

About WDC Western Digital Corporation

Western Digital is a leading vertically integrated supplier of hard disk drives. The HDD market is a practical duopoly, with Western Digital and Seagate being the two largest players. Western Digital designs and manufactures its HDDs, with much of the manufacturing and workforce located in Asia. The primary consumers of HDDs are data centers.

Share on Social Networks: